Skin Tissue Engineering via LINC Complex Disruption
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for generating skin tissue in vitro or ex vivo face challenges in replicating the complex biomechanical, biochemical, and structural properties of native skin environments, leading to issues with biofunctionality, compatibility, and variability, which impede their biomedical usage.
Innovation Solution
The method involves disrupting the LINC complex in skin cells using a dominant negative protein-based approach, allowing cells to proliferate and differentiate into skin tissue without the need for biomimetic scaffolds, thereby mimicking the structural and biomechanical properties of in vivo skin.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If biomimetic scaffolds are used to replicate native extracellular microenvironment, then structural and biochemical properties of skin tissue are improved, but device complexity and manufacturing difficulty increase significantly
Solution Approach 1:
The invention extracts and eliminates the scaffold component from the tissue engineering system. By using LINC complex disruptors, cells are induced to self-organize and form tissue structures without requiring external biomimetic scaffolds, thereby removing the complexity associated with scaffold design, fabrication, and integration while still achieving proper tissue architecture
Solution Approach 2:
The invention enables cells to self-organize and self-differentiate into proper skin tissue structures through LINC complex disruption. The cells inherently possess the capacity to form organized epidermal layers and appendages when given the appropriate molecular signal, eliminating the need for complex external structural guidance provided by scaffolds
2Reliability
If biomimetic scaffolds are used to replicate native microenvironment, then biofunctionality of cultured tissue is improved, but time and cost of tissue engineering increase
Solution Approach 1:
The invention applies preliminary molecular action by disrupting the LINC complex before tissue formation begins. This pre-treatment prime the cells to adopt proper tissue-specific behaviors and organization, accelerating the tissue engineering process and eliminating the time-consuming phases associated with scaffold integration and cell-scaffold adaptation
Solution Approach 2:
The invention replaces the mechanical scaffold system with a molecular/biochemical intervention (LINC complex disruption). Instead of using physical structures to guide tissue formation, the invention uses molecular signals to trigger intrinsic cellular programs for self-organization, thereby reducing both time and cost while maintaining biofunctionality
3Manufacturing precision
If biomimetic scaffolds are used to replicate native extracellular matrix, then cellular organization and architecture are improved, but variability and compatibility issues increase
Solution Approach 1:
The invention changes the fundamental parameter from physical scaffold structure to molecular LINC complex status. By controlling the molecular state of the LINC complex through disruption, the invention achieves consistent cellular organization and architecture across different cell types and experimental conditions, eliminating the variability inherent in scaffold-based approaches while improving compatibility
Data Source
Figure 1
Figure 2
Figure 3
AI summary
A method of creating skin tissue is described, particularly, an in vitro or ex vivo method for creating skin tissue. The invention extends to the use of agents that disrupt the LINC complex in a skin cell to create the skin tissue, and to using the created tissue in an assay to identify or screen anti-ageing compounds. The invention further extends to model skin tissues per se, uses thereof and to kits for creating such model skin tissues.